HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Association of Mitochondrial DNA Copy Number with Risk of Progression of Kidney Disease.

AbstractBACKGROUND AND OBJECTIVES:
Mitochondrial DNA copy number is a biomarker of mitochondrial function, which has been hypothesized to contribute to pathogenesis of CKD through podocyte injury, tubular epithelial cell damage, and endothelial dysfunction. The prospective association of mitochondrial DNA copy number with CKD progression has not been previously evaluated.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS:
Chronic Renal Insufficiency Cohort study participants had serum levels of mitochondrial DNA copy number calculated from probe intensities of mitochondrial single nucleotide polymorphisms genotyped on the Illumina HumanOmni 1-Quad Array. CKD progression was defined as kidney failure or halving of eGFR from baseline. Cox proportional hazards models were used to calculate hazard ratios for mitochondrial DNA copy number and risk of CKD progression.
RESULTS:
Among 2943 participants, mean age was 58 years, 45% were women, and 48% self-identified as Black. There were 1077 patients who experienced CKD progression over a median follow-up of 6.5 years. The incidence rate of CKD progression was highest for those in the lowest tertile of mitochondrial DNA copy number (tertile 1, 58.1; tertile 2, 50.8; tertile 3, 46.3 per 1000 person-years). Risk for CKD progression was higher for participants with lower levels of mitochondrial DNA copy number after adjustment for established risk factors (for tertile 1 versus 3, hazard ratio, 1.28 [95% confidence interval, 1.10 to 1.50]; for tertile 2 versus 3, hazard ratio, 0.99 [95% confidence interval, 0.85 to 1.16]; trend P=0.002). Similar results were seen among those with albuminuria (for tertile 1 versus 3, hazard ratio, 1.24; 95% confidence interval, 1.05 to 1.47), but there were no statistically significant associations among individuals without albuminuria (for tertile 1 versus 3, hazard ratio, 1.04; 95% confidence interval, 0.70 to 1.53; interaction P<0.001).
CONCLUSIONS:
These findings suggest lower mitochondrial DNA copy number is associated with higher risk of CKD progression, independent of established risk factors among patients with CKD.
AuthorsWilliam J He, Changwei Li, Zhijie Huang, Siyi Geng, Varun S Rao, Tanika N Kelly, L Lee Hamm, Morgan E Grams, Dan E Arking, Lawrence J Appel, Casey M Rebholz, CRIC Study Investigators
JournalClinical journal of the American Society of Nephrology : CJASN (Clin J Am Soc Nephrol) Vol. 17 Issue 7 Pg. 966-975 (07 2022) ISSN: 1555-905X [Electronic] United States
PMID35777833 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2022 by the American Society of Nephrology.
Chemical References
  • DNA, Mitochondrial
Topics
  • Albuminuria (epidemiology, genetics)
  • Cohort Studies
  • DNA Copy Number Variations
  • DNA, Mitochondrial (genetics)
  • Disease Progression
  • Female
  • Glomerular Filtration Rate
  • Humans
  • Male
  • Middle Aged
  • Mitochondria
  • Prospective Studies
  • Renal Insufficiency, Chronic (epidemiology, genetics)
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: